LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+11.42%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.25B
AUM Growth
+$1.25B
(+6.1%)
Cap. Flow
+$6.76M
Cap. Flow
% of AUM
0.54%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
377
New
103
Increased
165
Reduced
63
Closed
19
Top Buys
| 1 |
InMode
INMD
|
$18.4M |
| 2 |
Merck
MRK
|
$18M |
| 3 |
KE Holdings
BEKE
|
$13.9M |
| 4 |
Huazhu Hotels Group
HTHT
|
$11.3M |
| 5 |
Insulet
PODD
|
$11.2M |
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$38.6M |
| 2 |
iShares MSCI EAFE Value ETF
EFV
|
$33.9M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
$33.7M |
| 4 |
AbbVie
ABBV
|
$18.6M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
$12.5M |
Sector Composition
| 1 | Healthcare | 45.52% |
| 2 | Financials | 14.68% |
| 3 | Consumer Discretionary | 13.33% |
| 4 | Technology | 10.6% |
| 5 | Industrials | 5.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Neurocrine Biosciences
NBIX
$13.5B
| $16.4M | 1.31% |
137,450
-61,642
| -31% | -$7.36M |
|
27
Globe Life
GL
$11.4B
| $16.3M | 1.3% |
135,274
+35,274
| +35% | +$4.25M |
|
28
Apple
AAPL
$3.54T
| $15.5M | 1.24% |
119,494
-5,740
| -5% | -$746K |
|
29
Thor Industries
THO
$5.74B
| $15.1M | 1.21% |
200,000
-75,000
| -27% | -$5.66M |
|
|
30
Huazhu Hotels Group
HTHT
$11.2B
| $14.9M | 1.19% |
350,710
+267,310
| +321% | +$11.3M |
|
31
Equity Lifestyle Properties
ELS
$11.7B
| $14.5M | 1.16% |
225,157
+157
| +0.1% | +$10.1K |
|
32
United Therapeutics
UTHR
$17.7B
| $14.3M | 1.14% |
51,333
+3,539
| +7% | +$984K |
|
|
33
KE Holdings
BEKE
$21.8B
| $13.9M | 1.11% |
+994,724
| New | +$13.9M |
|
34
Alnylam Pharmaceuticals
ALNY
$58.6B
| $13.5M | 1.08% |
56,738
+21,125
| +59% | +$5.02M |
|
|
RCM
35
DELISTED
R1 RCM Inc. Common Stock
RCM
| $13.3M | 1.07% |
1,219,145
+595,684
| +96% | +$6.52M |
|
36
Baxter International
BAX
$12.1B
| $13.3M | 1.06% |
260,000
| – | – |
|
|
MDRX
37
DELISTED
Veradigm Inc. Common Stock
MDRX
| $13M | 1.04% |
738,973
| – | – |
|
38
Chemed
CHE
$6.7B
| $12.8M | 1.02% |
25,000
| – | – |
|
|
39
Insulet
PODD
$24.2B
| $12.5M | 1% |
42,623
+38,058
| +834% | +$11.2M |
|
40
Microsoft
MSFT
$3.76T
| $12.4M | 0.99% |
51,548
-3,881
| -7% | -$931K |
|
41
Eli Lilly
LLY
$661B
| $10.4M | 0.83% |
28,523
+24,806
| +667% | +$9.08M |
|
42
Virtus Investment Partners
VRTS
$1.3B
| $9.57M | 0.77% |
50,000
| – | – |
|
43
Option Care Health
OPCH
$4.7B
| $9.03M | 0.72% |
300,000
+25,000
| +9% | +$752K |
|
44
Glaukos
GKOS
$5.42B
| $8.86M | 0.71% |
202,913
+33,658
| +20% | +$1.47M |
|
45
Apellis Pharmaceuticals
APLS
$3.51B
| $8.81M | 0.7% |
170,353
+40,776
| +31% | +$2.11M |
|
|
SWAV
46
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $8.78M | 0.7% |
42,717
+12,015
| +39% | +$2.47M |
|
47
iRhythm Technologies
IRTC
$5.67B
| $8.69M | 0.7% |
92,804
+40,722
| +78% | +$3.81M |
|
|
HZNP
48
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8.48M | 0.68% |
+74,525
| New | +$8.48M |
|
49
Grab
GRAB
$20.1B
| $7.71M | 0.62% |
+2,395,330
| New | +$7.71M |
|
50
Cadence Design Systems
CDNS
$94.6B
| $6.86M | 0.55% |
42,684
+28,197
| +195% | +$4.53M |
|